Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2016

Jan 25, 2016

29745_dirs_2016-01-25_c46a459a-6ec8-4f77-8cae-9a74c3dc53e7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2015-12-31

Reporting Person: Ricks David A (SVP and Pres, Lilly Bio-Meds)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-03-31 Common Stock G 183 Disposed 61017 Direct
2015-07-23 Common Stock G 12 Disposed 61005 Direct
2015-12-17 Common Stock G 72 Disposed 60933 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4045 Indirect